| Literature DB >> 27652983 |
S Kale1, A J Nanavati1, N Borle1, S Nagral1.
Abstract
CONTEXT: Unfortunately, there is confusion among the medical community regarding the management of amoebic liver abscess (ALA). Therapeutic options range from simple pharmacotherapy to use of interventions like a needle or catheter aspiration under ultrasound guidance to surgical intervention. There is a plethora of thresholds for parameters such as the maximum diameter of the abscess and volume on ultrasound examination suggested by various authors to serve as a criterion to help to decide when to use which modality in these cases. AIMS: To assess the outcome of patients with uncomplicated ALA treated using a conservative approach. Moreover, to identify factors associated with its failure. SETTINGS ANDEntities:
Mesh:
Substances:
Year: 2017 PMID: 27652983 PMCID: PMC5394811 DOI: 10.4103/0022-3859.191004
Source DB: PubMed Journal: J Postgrad Med ISSN: 0022-3859 Impact factor: 1.476
Figure 1Flowchart showing patient selection and management algorithm
Clinical profile of study population
| Parameter | Result |
|---|---|
| Age | |
| Mean±SD (years) | 38.5±13.5 |
| Sex ( | |
| Male | 58 |
| Female | 2 |
| Symptomatology ( | |
| Pain in abdomen | 56 |
| Fever | 38 |
| Anorexia | 32 |
| Vomiting | 10 |
| Diarrhea | 11 |
| Jaundice | 6 |
| Respiratory complaints | 5 |
SD: Standard deviation
Figure 2Flowchart showing the distribution of patients as per therapy offered
Demographic profile and laboratory parameters in study population
| Parameter | Variable | Group 1 ( | Group 2 ( | |
|---|---|---|---|---|
| Demographic | ||||
| Sex* | Male | 47 | 11 | 0.31 |
| Female | 2 | 0 | ||
| Age (in years), mean±SD# | 38.9±13.2 | 42.9±12.7 | 0.37 | |
| Laboratory# (mean±SD) | Hemoglobin | 11.74±01.96 | 12.00±02.63 | 0.72 |
| Leukocyte count | 16,041.25±6281.18 | 16,436.36±8090.52 | 0.86 | |
| Platelet count | 254,361.22±127,959.54 | 214,272.73±149,715.79 | 0.41 | |
| Albumin | 3.12±00.41 | 2.79±00.47 | 0.02a | |
| Globulin | 3.44±00.56 | 3.57±00.69 | 0.49 | |
| Total bilirubin | 0.58±00.55 | 1.79±01.35 | 0.04a | |
| AST | 46.86±42.41 | 118.09±172.89 | 0.02a | |
| ALT | 42.22±25.86 | 92.00±131.91 | 0.02a | |
| ALP | 221.14±103.60 | 358.55±310.89 | 0.01a | |
| Prothrombin time | 16.31±04.36 | 16.27±02.72 | 0.97 |
*Analyzed using Fischer's test, aP<0.05, significant difference, #Analyzed using Student's t-test. AST: Aspartate aminotransferase, ALT: Alanine transaminase, ALP: Alkaline phosphatase, SD: Standard deviation
Ultrasonographic parameters in study population
| Parameter | Variable | Group 1 ( | Group 2 ( | |
|---|---|---|---|---|
| Number* | Single | 35 | 11 | 0.61 |
| Multiple | 14 | 0 | ||
| Site* | Right lobe | 41 | 9 | 0.16 |
| Left lobe | 4 | 2 | ||
| Both | 4 | 0 | ||
| Maximum diameter# (cm), mean±SD | 6.33±1.69 | 10.09±2.23 | <0.001a | |
| Volume (ml)#, mean±SD | 138.34±117.85399.73±244.46<0.001a | |||
*Analyzed using Fischer's test, aP<0.05, significant difference, #Analyzed using Student's t-test. SD: Standard deviation
Result of logistic regression analyses on parameters associated with outcome
| Variable | Coefficient ( | SE | Wald statistic ( | OR | 95% CI | |
|---|---|---|---|---|---|---|
| Albumin | −2.06378 | 1.3881 | 2.2105 | 0.127 | 0.0084-1.9288 | 0.1371 |
| Bilirubin | 0.33326 | 0.4744 | 0.4935 | 1.3955 | 0.5507-3.5363 | 0.4824 |
| AST | −0.018508 | 0.014714 | 1.5823 | 0.9817 | 0.9538-1.0104 | 0.2084 |
| ALT | 0.053971 | 0.035723 | 2.2826 | 1.0555 | 0.9841-1.1320 | 0.1308 |
| Maximum diameter | 3.60407 | 1.62104 | 4.9431 | 36.7476 | 1.5324-881.2223 | 0.0262a |
| Volume | −0.026434 | 0.015155 | 3.0423 | 0.9739 | 0.9454-1.0033 | 0.0811 |
aP<0.05, significant association. Overall model fit significance level P<0.001. AST: Aspartate aminotransferase, ALT: Alanine transaminase, SE: Standard error, OR: Odds ratio, CI: Confidence interval
Figure 3Receiver operating characteristic curve plotted using maximum diameter, table below shows the area under curve, standard error, confidence interval, and P value